CTN-0100 Study Reaches Recruitment Milestone

The CTN-0100 team is pleased to announce that the study reached its recruitment goal for the Discontinuation Phase (and the study overall) in May. The final participant was successfully randomized in June, marking the end of recruitment after four years of sustained effort!

Over the course of the study, all 18 participating sites contributed to an extraordinary achievement: at least one participant was randomized for every calendar day during the four-year recruitment period. Despite challenges such as medication and app disruptions, the research teams demonstrated exceptional persistence and consistency.

In total, 1,140 participants were randomized into the Retention Phase and 376 into the Discontinuation Phase. Congratulations to all involved in reaching this significant study milestone!

Posted June 27, 2025